Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
J Virol. 2012 Jan;86(1):36-48. doi: 10.1128/JVI.00717-11. Epub 2011 Oct 19.
It is well established that the Nef proteins of human and simian immunodeficiency viruses (HIV and SIV) modulate major histocompatibility complex class I (MHC-I) cell surface expression to protect infected cells against lysis by cytotoxic T lymphocytes (CTLs). Recent data supported the observation that Nef also manipulates CTLs directly by down-modulating CD8αβ (J. A. Leonard, T. Filzen, C. C. Carter, M. Schaefer, and K. L. Collins, J. Virol. 85:6867-6881, 2011), but it remained unknown whether this Nef activity is conserved between different lineages of HIV and SIV. In this study, we examined a total of 42 nef alleles from 16 different primate lentiviruses representing most major lineages of primate lentiviruses, as well as nonpandemic HIV-1 strains and the direct precursors of HIV-1 (SIVcpz and SIVgor). We found that the vast majority of these nef alleles strongly down-modulate CD8β in human T cells. Primate lentiviral Nefs generally interacted specifically with the cytoplasmic tail of CD8β, and down-modulation of this receptor was dependent on the conserved dileucine-based motif and two adjacent acidic residues (DD/E) in the C-terminal flexible loop of SIV Nef proteins. Both of these motifs are known to be important for the interaction of HIV-1 Nef with AP-2, and they were also shown to be critical for down-modulation of CD4 and CD28, but not MHC-I, by SIV Nefs. Our results show that down-modulation of CD4, CD8β, and CD28 involves largely overlapping (but not identical) domains and is most likely dependent on conserved interactions of primate lentiviral Nefs with cellular adaptor proteins. Furthermore, our data demonstrate that Nef-mediated down-modulation of CD8αβ is a fundamental property of primate lentiviruses and suggest that direct manipulation of CD8+ T cells plays a relevant role in viral immune evasion.
已证实,人类和猿猴免疫缺陷病毒(HIV 和 SIV)的 Nef 蛋白可调节主要组织相容性复合体 I 类(MHC-I)细胞表面表达,以保护受感染的细胞免受细胞毒性 T 淋巴细胞(CTL)的裂解。最近的数据支持这样一种观察结果,即 Nef 还通过下调 CD8αβ 直接操纵 CTL(J. A. Leonard、T. Filzen、C. C. Carter、M. Schaefer 和 K. L. Collins,J. Virol. 85:6867-6881,2011),但尚不清楚这种 Nef 活性是否在不同的 HIV 和 SIV 谱系之间保守。在这项研究中,我们检查了来自 16 种不同灵长类慢病毒的总共 42 个 nef 等位基因,这些灵长类慢病毒代表了灵长类慢病毒的大多数主要谱系,以及非大流行性 HIV-1 株和 HIV-1 的直接前体(SIVcpz 和 SIVgor)。我们发现,这些 nef 等位基因中的绝大多数强烈下调人类 T 细胞中的 CD8β。灵长类慢病毒 Nef 通常特异性地与 CD8β 的细胞质尾巴相互作用,并且这种受体的下调依赖于 SIV Nef 蛋白 C 末端柔性环中保守的二亮氨酸基基序和两个相邻的酸性残基(DD/E)。这两个基序都已知对于 HIV-1 Nef 与 AP-2 的相互作用很重要,并且它们也被证明对于 SIV Nef 下调 CD4 和 CD28 但不下调 MHC-I 是关键的。我们的结果表明,CD4、CD8β 和 CD28 的下调涉及很大程度上重叠(但不相同)的结构域,并且很可能依赖于灵长类慢病毒 Nef 与细胞衔接蛋白的保守相互作用。此外,我们的数据表明,Nef 介导的 CD8αβ 下调是灵长类慢病毒的基本特性,并表明直接操纵 CD8+T 细胞在病毒免疫逃避中起相关作用。